Abstract
Techniques for contraception are not the invention of recent biomedical research. Contraception has been sought and used by people for ages, and for a long time has been primarily an issue of politics, and not of technology.1 However, the politics of contraception changed dramatically with the shift in technological base from products developed by lay men and women (condoms, diaphragms, and pessaries) to products emerging from biomedical laboratories, from medical surgery, and from the drug industry (the “Pill,” IUDs, and laparoscopic tubal ligations). In fact, what is new about contraception in the last thirty years is the promotion of the development of new biomedical contraceptives by scientists and physicians, national governments, private groups concerned with the rate of population growth, and the drug industry. Because of this, the research and development of new contraceptives has become entwined in politics, both national and international. Furthermore, in the last ten years, these politics of contraceptive research have changed dramatically, largely out of the growing awareness of the question of safety of biomedical technological contraceptives. What has been realized is that there are two critical considerations in the evaluation of safety: one is “risk” and the other is “safety.”
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Gordon, L., Woman’s Body, Woman’s Right: A History of Birth Control, New York, Viking Press, 1977.
Lowrance, W. W., Of Acceptable Risk: Science and the Determination of Risk, Los Angeles, California, Kaufman, 1976.
Norsigian, J., “Redirecting Contraceptive Research,” Science for the People, January/February, 27 (1979).
Green, K., M. Bygdeman, K. Bremme, “Interruption of Early First Trimester Pregnancy by Single Vaginal Administration of 15-Methyl- P6F2-Alpha-methyl ester,” Contraception 18, 557 (1978).
Chvapil, M., T. Chvapil, S. Jacobs, T. A. Owen, H. L. Horton, M. W. Heine, “Laboratory and Clinical Testing of Collagen Sponge as Intravaginal Contraceptive,” Contraception 15, 693 (1977).
Chvapil, M., C. W. Lischer, T. B. Campbell, M. Kantor, T. A. Owen, T. Chvapil, “Ultrastructure of the Vaginal Tissue of Rabbits Treated with Collagen Sponge Alone and Medicated with Zinc and Copper Salts and Copper Wire,” Fertil. Steril. 30, 461 (1978).
Editor information
Rights and permissions
Copyright information
© 1980 Humana Press Inc.
About this chapter
Cite this chapter
Korenbrot, C.C. (1980). Value Conflicts in Biomedical Research into Future Contraceptives. In: Holmes, H.B., Hoskins, B.B., Gross, M. (eds) Birth Control and Controlling Birth. Contemporary Issues in Biomedicine, Ethics, and Society. Humana Press. https://doi.org/10.1007/978-1-4612-6005-9_5
Download citation
DOI: https://doi.org/10.1007/978-1-4612-6005-9_5
Publisher Name: Humana Press
Print ISBN: 978-0-89603-023-7
Online ISBN: 978-1-4612-6005-9
eBook Packages: Springer Book Archive